Latest Novo Holdings A/S Stock Portfolio
$1.45Billion
Equity Portfolio Value
Last Reported on: 15 May, 2024
About Novo Holdings A/S and it’s 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Novo Holdings A/S reported an equity portfolio of $1.4 Billions as of 31 Mar, 2024.
The top stock holdings of Novo Holdings A/S are ASML, , CRM. The fund has invested 12.2% of it's portfolio in ASML HOLDING N V and 11.2% of portfolio in BROOKFIELD CORP.
The fund managers got completely rid off TAIWAN SEMICONDUCTOR MFG LTD (TSM), EDGEWISE THERAPEUTICS INC (EWTX) and CYMABAY THERAPEUTICS INC (CBAY) stocks. They significantly reduced their stock positions in PHARVARIS N V (PHVS), APPLE INC (AAPL) and IO BIOTECH INC (IOBT). Novo Holdings A/S opened new stock positions in EDGEWISE THERAPEUTICS INC (EPC), VIRIDIAN THERAPEUTICS INC (VRDN) and ARRIVENT BIOPHARMA INC. The fund showed a lot of confidence in some stocks as they added substantially to LEXEO THERAPEUTICS INC.
The top stock holdings of Novo Holdings A/S are ASML, , CRM. The fund has invested 12.2% of it's portfolio in ASML HOLDING N V and 11.2% of portfolio in BROOKFIELD CORP.
The fund managers got completely rid off TAIWAN SEMICONDUCTOR MFG LTD (TSM), EDGEWISE THERAPEUTICS INC (EWTX) and CYMABAY THERAPEUTICS INC (CBAY) stocks. They significantly reduced their stock positions in PHARVARIS N V (PHVS), APPLE INC (AAPL) and IO BIOTECH INC (IOBT). Novo Holdings A/S opened new stock positions in EDGEWISE THERAPEUTICS INC (EPC), VIRIDIAN THERAPEUTICS INC (VRDN) and ARRIVENT BIOPHARMA INC. The fund showed a lot of confidence in some stocks as they added substantially to LEXEO THERAPEUTICS INC.
New Buys
| Ticker | $ Bought |
|---|---|
| EDGEWISE THERAPEUTICS INC | 115,722,000 |
| VIRIDIAN THERAPEUTICS INC | 19,261,000 |
| ARRIVENT BIOPHARMA INC | 19,237,700 |
| METAGENOMI INC | 18,348,300 |
| KYVERNA THERAPEUTICS INC | 17,388,000 |
New stocks bought by Novo Holdings A/S
Additions
| Ticker | % Inc. |
|---|---|
| LEXEO THERAPEUTICS INC | 25.27 |
Additions to existing portfolio by Novo Holdings A/S
Reductions
| Ticker | % Reduced |
|---|---|
| PHARVARIS N V | -24.12 |
| APPLE INC | -17.38 |
| IO BIOTECH INC | -11.46 |
| SALESFORCE INC | -9.49 |
| ASML HOLDING N V | -7.7 |
| 4D MOLECULAR THERAPEUTICS IN | -6.67 |
| BLUEPRINT MEDICINES CORP | -0.14 |
| CRINETICS PHARMACEUTICALS IN | -0.13 |
Novo Holdings A/S reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| SPRUCE BIOSCIENCES INC | -19,696,400 |
| EDGEWISE THERAPEUTICS INC | -66,424,400 |
| LAVA THERAPEUTICS NV | -2,967,550 |
| RALLYBIO CORP | -4,225,190 |
| CYMABAY THERAPEUTICS INC | -21,258,000 |
| TAIWAN SEMICONDUCTOR MFG LTD | -73,921,100 |
Novo Holdings A/S got rid off the above stocks
Current Stock Holdings of Novo Holdings A/S
Last Reported on: 15 May, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| AAPL | APPLE INC | 2.16 | 182,960 | 31,374,000 | REDUCED | -17.38 | |
| ABCL | ABCELLERA BIOLOGICS INC | 0.35 | 1,126,920 | 5,104,920 | UNCHANGED | 0.00 | |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 1.22 | 118,383 | 17,692,300 | UNCHANGED | 0.00 | |
| ASML | ASML HOLDING N V | 12.22 | 182,536 | 177,146,000 | REDUCED | -7.7 | |
| BABA | ALIBABA GROUP HLDG LTD | 2.50 | 500,827 | 36,239,800 | UNCHANGED | 0.00 | |
| BAM | BROOKFIELD ASSET MANAGMT LTD | 1.82 | 627,207 | 26,355,200 | UNCHANGED | 0.00 | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 2.71 | 450,000 | 39,303,000 | UNCHANGED | 0.00 | |
| BPMC | BLUEPRINT MEDICINES CORP | 2.35 | 358,626 | 34,019,300 | REDUCED | -0.14 | |
| CABO | CABLE ONE INC | 3.46 | 118,403 | 50,099,900 | UNCHANGED | 0.00 | |
| CBAY | CYMABAY THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| CORT | CORCEPT THERAPEUTICS INC | 4.19 | 2,411,360 | 60,742,200 | UNCHANGED | 0.00 | |
| CRM | SALESFORCE INC | 9.98 | 480,160 | 144,615,000 | REDUCED | -9.49 | |
| CRNX | CRINETICS PHARMACEUTICALS IN | 3.55 | 1,098,600 | 51,425,500 | REDUCED | -0.13 | |
| EPC | EDGEWISE THERAPEUTICS INC | 7.98 | 6,344,430 | 115,722,000 | NEW | ||
| EWTX | EDGEWISE THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 3.08 | 1,400,000 | 44,604,000 | REDUCED | -6.67 | |
| FOLD | AMICUS THERAPEUTICS INC | 2.03 | 2,500,000 | 29,450,000 | UNCHANGED | 0.00 | |
| GLTO | GALECTO INC | 0.13 | 2,497,790 | 1,948,280 | UNCHANGED | 0.00 | |
| INSM | INSMED INC | 2.51 | 1,339,300 | 36,335,300 | UNCHANGED | 0.00 | |
| INSP | INSPIRE MED SYS INC | 0.97 | 65,524 | 14,073,900 | UNCHANGED | 0.00 | |
| IOBT | IO BIOTECH INC | 0.61 | 5,088,260 | 8,802,690 | REDUCED | -11.46 | |
| LVTX | LAVA THERAPEUTICS NV | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| MIRM | MIRUM PHARMACEUTICALS INC | 2.60 | 1,500,000 | 37,680,000 | UNCHANGED | 0.00 | |
| MQ | MARQETA INC | 0.18 | 441,558 | 2,631,690 | UNCHANGED | 0.00 | |
| PCVX | VAXCYTE INC | 3.98 | 845,000 | 57,722,000 | UNCHANGED | 0.00 | |
| PHVS | PHARVARIS N V | 1.86 | 1,168,030 | 26,993,200 | REDUCED | -24.12 | |
| RCKT | ROCKET PHARMACEUTICALS INC | 1.95 | 1,050,000 | 28,287,000 | UNCHANGED | 0.00 | |
| RLYB | RALLYBIO CORP | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| SPRB | SPRUCE BIOSCIENCES INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| SPRO | SPERO THERAPEUTICS INC | 0.06 | 468,902 | 806,511 | UNCHANGED | 0.00 | |
| TMCI | TREACE MED CONCEPTS INC | 0.32 | 360,000 | 4,698,000 | UNCHANGED | 0.00 | |
| TSM | TAIWAN SEMICONDUCTOR MFG LTD | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| VERV | VERVE THERAPEUTICS INC | 1.83 | 2,000,000 | 26,560,000 | UNCHANGED | 0.00 | |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1.33 | 1,100,000 | 19,261,000 | NEW | ||
| BROOKFIELD CORP | 11.21 | 3,880,230 | 162,465,000 | UNCHANGED | 0.00 | ||
| LANZATECH GLOBAL INC | 3.38 | 15,814,800 | 48,946,900 | UNCHANGED | 0.00 | ||
| CARGO THERAPEUTICS INC | 1.93 | 1,250,000 | 27,900,000 | UNCHANGED | 0.00 | ||
| LEXEO THERAPEUTICS INC | 1.77 | 1,638,300 | 25,688,500 | ADDED | 25.27 | ||
| ARRIVENT BIOPHARMA INC | 1.33 | 1,077,140 | 19,237,700 | NEW | |||
| METAGENOMI INC | 1.27 | 1,739,180 | 18,348,300 | NEW | |||
| KYVERNA THERAPEUTICS INC | 1.20 | 700,000 | 17,388,000 | NEW |